NICE seeking patient experts for brentuximab vedotin Technology Appraisal.
News and views
Key lymphoma treatments continue to be available to NHS patients in England via the Cancer Drugs Fund.
The Blood Cancers Alliance have sent an open letter to the Prime Minister and Secretary of State for Health, for publication in The Times today (4 November 2015). The letter is a response to the Cancer Drugs Fund (CDF) delistings which are scheduled to come into force today.
Chronic lymphocytic leukaemia (CLL) patients at St Bartholomew’s Hospital in London can now have follow up appointments over the phone or via video link thanks to a nurse-led, remote patient monitoring programme.
The Lymphoma Association has been identified as a reliable source of information and support for patients in new guidelines published by the London Cancer Alliance (LCA) this month (October).
The haemato-oncology guidelines, aimed at health professionals, will provide evidence-based clinical information and protocols on all aspects of care.